Outcome measures in asthma

Thorax

Volumn 55, Issue SUPPL. 1, 2000, Pages

  Barnes, N C ^a  

^a LONDON CHEST HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID; FORMOTEROL;

ARTICLE; ASTHMA; CIRCADIAN RHYTHM; DISEASE CONTROL; DISEASE DURATION; DISEASE SEVERITY; HUMAN; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SYMPTOM; TREATMENT OUTCOME;

EID: 0033940869     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.55.suppl_1.s70     Document Type: Article

References (19)

1. 1 National Asthma Education and Prevention Program Expert Panel Report 2. Guidelines for the diagnosis and management of asthma. NIH Publication No. 97-4051. Bethesda, Maryland: NHLBI, 199 7.
2. 2 British Thoracic Society, The National Asthma Campaign, and The Royal College of Physicians of London in association with The General Practitioner in Asthma Group, The British Association of Accident and Emergency Medicine, The British Paediatric Respiratory Society and The Royal College of Paediatric and Child Health. The British guidelines on asthma management: 1995 review and position statement. Thorax 1996;52(Suppl 1):S1-2 1.
3. 3 Global Initiative for Asthma (GINA). Asthma management and prevention. NIH Publication No. 96-3659A. Bethesda, Maryland: NHLBI, 199 5.
4. 4 British Thoracic Society. Guidelines on the management of asthma. Thorax 1993;48:S1-2 4.
5. 5 Asthma outcome measures. Am J Respir Crit Care Med 1994;149:S1-9 0.
6. 6 Guidelines for investigating new drugs in asthma. J Soc Pharmaceutical Med 199 3.
7. 7 Pauwels RA, Lofdahl C-G, Postma DS, et al on behalf of the FACET International Study Group. Additive effects of inhaled formoterol and budesonide in reducing asthma exacerbations: a one-year, controlled study. N Engl J Med 1997;337:1405-1 1.
8. 8 Tattersfield AE, Postma DS, Barnes PJ, et al on behalf of the FACET International Study Group. Exacerbations of asthma: a description study of 425 severe exacerbations. Am J Respir Crit Care Med 1999; 160:594-9.
9. 9 Reddel H, Ware S, Marks G, et al. Differences between asthma exacerbations and poor asthma control. Lancet 1999;353:364-9.
10. 10 Gruberg K, Timmers MC, de Klerk EP, et al. Experimental rhinovirus 16 causes variable airflow obstruction in subjects with atopic asthma. Am J Respir Crit Care Med 1999;160:1375-8 0.
11. 11 Greening AP, Ind PW, Northfield M, et al. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994;344:219-2 4.
12. 12 Woolcock A, Landback R, Ringdal N, et al. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 1996;153:1481-8.
13. 13 Virchow JC, Hassall SM, Summerton L, et al. Improved asthma control over 6 weeks with zafirlukast in patients on high dose inhaled corticosteroids. Eur Respir J 1998;10(Suppl 25): 4375 (abstract ).
14. 14 Evans DJ, Taylor DA, Zetterstrom O, et al. A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. N Engl J Med 1997;337:1412-8.
15. 15 Ukena D, Harnest U, Sakalauskas R, et al. Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma. Eur Respir J 1998;10:2754-6 0.
16. 16 Malmstrom K, Rodriguez-Gomez G, Guerra J, et al. Oral montelukast, inhaled beclomethasone and placebo for chronic asthma, a randomised, controlled trial. Ann Intern Med 1999;130:487-9 5.
17. 17 Sont JK, Willem LN, Bel EH, et al. Clinical control and histopathologic control of asthma under using airway hyperresponsiveness as an additional guide to long-term treatment. Am J Respir Crit Care Med 1999;59:1043-5 1.
18. 18 Berlyne GS, Barnes NC. No role for NO in asthma. Lancet 2000 (in press ).
19. 19 Ptrogen JM, Yandava CN, Dube L, et al. Pharmacogenetic association between ALOx5 promoter genotype and the response to anti asthma treatment. Nature Genet 1999;22:168-9 .